ArticlePloS one2026
Prevalence and associated risk factors of Pseudomonas aeruginosa infection in Diabetic wounds in Duhok province, Iraq.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsDiabetes mellitus is a chronic metabolic disorder and a major global health problem, predisposing patients to wound infections, with Pseudomonas aeruginosa being a frequent and resistant pathogen. This study aimed to identify P. aeruginosa, assess associated risk factors, and determine its antibiotic susceptibility pattern in diabetic wound infections in Duhok Province, Kurdistan Region, Iraq.
methodsThis cross-sectional study was conducted from June 2024 to July 2025 in Duhok Province, Kurdistan Region, Iraq. A total of 141 wound swab samples were collected from diabetic patients aged ≥18 years. P. aeruginosa was identified using biochemical tests, Vitek®2, and 16S rDNA PCR. Antimicrobial susceptibility testing was performed by the disc diffusion method on Mueller-Hinton agar, and data were analyzed using GraphPad Prism software.
resultsOut of 141 wound infection samples collected from diabetic patients, P. aeruginosa was isolated in 44.68% of cases. Overall, sociodemographic factors showed no significant association with PsA infection, except for occupational status in the multivariable analysis 0.12 [0.02-0.97, p = 0.046] and overweight 0.29 [0.10-0.82, p = 0.019]. Clinically, most variables including HbA1c, duration of diabetes, comorbidities, treatment type, and wound characteristics were not significantly associated with PsA infection. The only significant predictor was wound location, with leg-region infections showing a higher risk of PsA 3.94 [1.24-12.5, p = 0.02]. P. aeruginosa isolates showed high levels of multidrug resistance, especially to aztreonam, ceftazidime, cefepime, and tobramycin. Colistin showed the lowest resistance and highest sensitivity, followed by relatively better susceptibility to carbapenems.
conclusionP. aeruginosa is a common cause of wound infections in patients with diabetes mellitus, with its prevalence significantly associated with body mass index, occupational status and wound location, with leg-region wounds showing a higher risk. P. aeruginosa isolates demonstrated high multidrug resistance, although colistin and carbapenems retained relatively better activity. Early detection and appropriate antibiotic selection are essential to reduce complications and improve patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.